Leiv Lea Insider Profile

Leiv Lea, VP Fin & Admin & CFO at Pharmacyclics, holds 20.89K shares in Pharmacyclics (Ticker: PCYC), holds 282.44K shares in Corvus Pharmaceuticals (Ticker: CRVS). Most recently, Leiv Lea ― shares of Pharmacyclics on ― for an estimated value of ―.
Leiv Lea

Leiv Lea
Pharmacyclics (PCYC)
VP Fin & Admin & CFO

Ranked #68,515 out of 103,103 Corporate Insiders

Profitable Transactions

1 out of 4 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Leiv Lea's holdings

Insider Roles

Corvus Pharmaceuticals
Roles that Leiv Lea holds in companies

Most Profitable Insider Trade

Corvus Pharmaceuticals
Rating:Informative Buy
Date:Dec 27, 2018 - Dec 27, 2019
The most profitable trade made by Leiv Lea

Leiv Lea's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Corvus Pharmaceuticals
Dec 15, 2022
Informative Buy
List of latest transactions for each holding click on a transaction to see Leiv Lea's performance on stock

Leiv Lea insider profile FAQ

What is the percentage of profitable transactions made by Leiv Lea?
The percentage of profitable transactions made by Leiv Lea is 25%.
    What is the average return per transaction made by Leiv Lea?
    The average return per transaction made by Leiv Lea is -10.70%.
      What stocks does Leiv Lea hold?
      Leiv Lea holds: PCYC, CRVS stocks.
        What was Leiv Lea’s latest transaction?
        Leiv Lea latest transaction was an Uninformative Buy of ―.
          What was Leiv Lea's most profitable transaction?
          Leiv Lea’s most profitable transaction was an Informative Buy of CRVS stock on December 27, 2018. The return on the trade was 34.60%.
            What is Leiv Lea's role in Pharmacyclics?
            Leiv Lea's role in Pharmacyclics is VP Fin & Admin & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.